Cardio Diagnostics-CW26CDIOWPreferred / convertible

13F holders, Q1 2024 (March 31)
12holders
1famous investor
$0.17avg. 13F price*

At the end of Q1 2024, 12 institutions reported holding Cardio Diagnostics-CW26 (CDIOW) in their 13F filings. The largest holders were Boothbay Fund Management, LLC ($86K), Walleye Capital LLC ($25K) and EHP Funds Inc. ($24K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Cardio Diagnostics-CW26
CUSIP
14159C111
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 12Q1 2024Q2 2024: 9Q2 2024Q3 2024: 10Q3 2024Q4 2024: 6Q4 2024Q1 2025: 7Q1 2025Q2 2025: 10Q2 2025Q3 2025: 10Q3 2025Q4 2025: 6Q4 2025Q1 2026: 7Q1 2026Q2 2026: 7Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions1$3K
Exits2$13K

Ownership 12 holders

Boothbay Fund Management, LLC — No change 60,540 $86K
Walleye Capital LLC — No change 234,907 $25K
EHP Funds Inc. — No change 228,952 $24K
Saba Capital Management, L.P. — No change 199,839 $21K
Walleye Trading LLC — No change 132,265 $14K
Clear Street LLC — Add +0.1% 83,142 $9K
Context Capital Management, LLC — No change 81,500 $9K
D. E. Shaw & Co. — No change 74,822 $7K
HRT Financial LP — Add +5.8% 36,936 $4K
Susquehanna International Group, LLP — New 25,994 $3K
Virtu Financial LLC — Add +39.1% 14,513 $2K
UBS Group AG — Add +458.4% 5,126 $543

"% of holder's portfolio" is CDIOW's weight in each manager's 13F, not the share of Cardio Diagnostics-CW26 the manager owns.